YEATS2 and liposarcoma: Amplification of YEATS2 has been identified in ovarian cancer, head and neck cancer, esophageal cancer, and uterine cancer (Mi et al., 2017), as well as both well-differentiated and dedifferentiated liposarcoma (Beird et al., 2018).